Truist lowered the firm’s price target on Leidos (LDOS) to $165 from $185 and keeps a Buy rating on the shares following “strong” Q4 results.

Truist lowered the firm’s price target on Inspire Medical (INSP) to $235 from $250 and keeps a Buy rating on the shares. The company’s Q4 ...

Truist Securities adjusted its price target for Inspire Medical Systems (NYSE:INSP) stock, lowering it from $250.00 to $235.00 while maintaining a Buy rating. The adjustment follows the company's ...

Truist Securities updated its analysis of Equitable Holdings Inc (NYSE:EQH), increasing the price target to $60 from the ...

Truist Financial (NYSE:TFC) stock gained 3.0% in Friday premarket trading after the bank issued strong Q1 2025 guidance and scored a Q4 earnings beat as both net interest income and income from ...

William Rogers; Chairman of the Board, Chief Executive Officer; Truist Financial Corp Michael Maguire; Chief Financial Officer, Senior Executive Vice President; Truist Financial Corp Scott Siefers ...

Truist Financial is a leading U.S. commercial ... including share repurchases planned at $500 million for Q4 2024. Management projected cautious optimism for 2025, focusing on maintaining positive ...

Truist analyst Youssef Squali lowered the firm’s price target on Uber (UBER) to $90 from $95 and keeps a Buy rating on the ...

Truist's net income came to $1.2 billion, or 91 cents per share in Q4, a rise from $1.1 billion, or 81 cents per share in the same period a year earlier. The bank's latest Q4 net income beat ...